Status:
COMPLETED
BPPV Treatment in Biaxial Rotational Chair
Lead Sponsor:
Haukeland University Hospital
Conditions:
Benign Paroxysmal Positional Vertigo
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Benign paroxysmal positional vertigo (BPPV) represents the most common cause of labyrinthine vertigo with a lifetime prevalence of 2.4 percent. Onset is most common between the fifth and seventh decad...
Detailed Description
There has been extended research to improve the techniques and develop better and more reliable methods for diagnosing and treating BPPV efficiently. An important part in this technique evolution is t...
Eligibility Criteria
Inclusion
- subjects over 18 years with benign paroxysmal positional vertigo(BPPV)
Exclusion
- BPPV previously treated with reposition maneuvers within the last 12 months.
- Cochlear Implant (CI).
- Asymmetrical hearing loss.
- Unusual headache.
- Neurological disease.
- Inner ear disease other than BPPV.
- Semicircular canal paresis.
- Drug that causes dizziness/nystagmus.
- Chemotherapy.
- Hospital admission due to head trauma within the last 12 months.
- Closeness to study group.
- Downbeating nystagmus or upbeating nystagmus without torsional component.
- Extensive spontaneous nystagmus that complicates gait interpretation.
- Cannot tolerate both treatments.
- Pregnancy.
- Bilateral affection of the semicircular canals.
- More than two semicircular canals affected on one side.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT01905800
Start Date
August 1 2013
End Date
July 1 2017
Last Update
November 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5021